Welcome back to our blog series on National Member News!

We are excited about getting our National Member news out to the world, so more people can find out what it is happening in each country and each member organisation! We caught up with Viola Zajk from Lupus Poland, who talked to us about the incredible work the organisation is doing, the needs of lupus patients in Poland and much more!

Portrait of Viola Zajk with a neutral expression, wearing a beige sweater and a black top.

 

How do you keep in touch with or have contact with your members?

 

In addressing how we stay connected with our members, we emphasise the use of digital media, particularly Facebook (https://www.facebook.com/lupuspoland/) as a primary communication channel. We are also reachable via email and phone, providing personal responses to members’ questions. Recognising the need to evolve, we are also working on launching a newsletter and improving our website to share the latest news and developments with the world.

 

Additionally, we have ventured into audio media with the creation of ‘Radio Reuma’ on Spotify. This podcast, available in Polish, currently features episodes on lupus, including on diagnosis and psychological support, and has also attracted interest from medical professionals. We plan to expand the podcast with more episodes, making it even more accessible to a wider audience.

 

In terms of healthcare initiatives, we worked hard for some time to advocate for a programme for biological treatment; this was successful with the rollout starting in October, enhancing medication accessibility for patients. We are also part of developing a comprehensive care programme for newly diagnosed patients with various forms of inflammatory arthritis, including lupus, to be piloted in 15 locations across Poland. This programme aims to offer coordinated care with multiple specialists in one place, starting in January for newly diagnosed patients. This is a significant step towards centralised and efficient, multi-disciplinary healthcare for lupus patients in Poland.

 

Did you have any special meetings or webinars during the past year (World Lupus Day, Rare Disease Day, Annual General Meeting etc)?

 

We have been actively developing educational webinars, primarily focused on lupus. We have also launched “Surrounded by Care” (https://3majmysierazem.pl/edukacja/otoczeni-wspraciem/ ), a new educational and informational campaign for lupus.

These webinars may not yet be featured on our Lupus Poland page, but they are available on our main website, specifically for the needs of lupus patients. Our efforts are continued to expand these resources with even more podcasts and an upcoming webinar which we hope will take place in December with the help of a renowned rheumatologist in Poland. This collaboration reflects our strong commitment to providing valuable information and support to our community.

 

Our team of wonderful volunteers is key to our efforts. We are currently seeking additional volunteers to help us manage our expanding range of activities and initiatives. There’s a lot to do, and we’re excited about the positive impact we can make, especially as we look towards 2025 when Poland will assume the EU Presidency. Our preparation is already in full swing, with plans to bring extensive information about rheumatology needs to the forefront. This is particularly important, as we have observed an increase in autoimmune disease diagnoses. Our goal is to enhance support for autoimmune diseases across Europe, building on the ideas and momentum generated pre-Covid for better support of people with rheumatological conditions.

 

Has Digital Health improved or changed in your country?

 

It’s clear that we are witnessing significant advancements. We now have the ability to make appointments online, access our medical records, consult with doctors virtually, and these capabilities are continuously improving. A great development is our shift towards digital platforms that can handle prescriptions and referrals, mostly eliminating the need for paper-based processes.

 

One key initiative we are working on is the development of a comprehensive digital platform. This platform already exists and facilitates actions like signing up for COVID vaccinations, whereby patients automatically receive a vaccine invitation and can then select the date and time and their preferred vaccination site. Our aim is to expand this functionality to include all types of medical referrals, improving the ease with which patients can find and schedule appointments with doctors near them.

 

We also appreciate not having to physically visit a doctor for certain needs, like prescription renewals. The ability to handle these matters with a phone call represents a more efficient and patient-friendly approach. This digital health transformation is an ongoing process in our country, with improvements being made every month!

 

What would you most need as support in your country for lupus?

 

We have a strong hope in a new programme designed to provide comprehensive, coordinated care for lupus patients. This programme aims to offer a centralised location where patients can access all the support they need, through a multi-disciplinary team.

 

Additionally, we are focusing on developing platforms that provide essential information on living with lupus, including self-care. Part of this initiative is, of course, the Polish version of the Lupus100 project, which is set to launch in the next few months.

 

This project will offer valuable information on topics patients frequently wonder about: such as how a person can prepare for their first doctor’s visit, what information and documents to bring, and other practical concerns. There is also a need for education around basic healthcare procedures, like urine sample collection. I am reminded in mentioning this of a past awareness campaign featuring Toni Braxton, which used graphics to illustrate the correct method of collecting a urine sample for a whole day. This is a task many patients tell us they find challenging and are often hesitant to ask about. Realising the potential impact of such simple yet crucial information, we believe that educating patients, especially the newly diagnosed on many different aspects of the disease and its treatments, is vital.

  

We emphasise the importance of patient education, starting from the basics and gradually building up to more complex information. This approach is essential not only for supporting people who have had lupus for many years, but for guiding newly diagnosed patients who are just beginning their journey with lupus. Our goal is to improve things so no newly diagnosed patient will face the same challenges and uncertainties that many of us experienced at the start of our lupus journey. Part of that means ensuring people have the necessary knowledge and support right from the beginning.

 

We also aim to develop education around new treatments for all lupus patients. We have therefore expanded our own knowledge and become Clinical Trial Ambassadors. This allows us to better educate others around clinical trials and how to find the right one.

 

Is there anything you think Lupus Europe could help your organisation with?  

 

Yes! The exchange of information and new ideas among patient organisations across Europe is so important. By sharing successful strategies and programmes like those we have established in Poland with organisations in other countries or with other countries where there are no organisations yes, we can collectively enhance patient support. When an approach or resource proves effective for people in one country, that can encourage others to adopt and adapt these initiatives to fit their needs within their own countries. This collaborative effort can significantly contribute to the improvement of lupus care and support throughout Europe.

 

Is there any topic/theme/area that you think Lupus Europe should focus on, on something where European collaboration would make sense?

 

The topic of cross-border healthcare within Europe is definitely an area that needs attention and collaboration. The challenge faced by rheuma patients generally and lupus patients specifically, when moving countries can be significant. There is a lack of guidance on navigating healthcare systems in a new country, especially when it comes to transferring medical prescriptions and understanding different healthcare rules. This issue is not just relevant for young people who might move for their studies, but it also affects those who may travel for leisure or relocate for work within Europe.

 

Dealing with healthcare across European borders can be complex and daunting. A key point of focus should be providing patients with essential information on what they need to know, where to go, and what documents they need to have in the context of different health systems across countries. At the moment each country presents its own unique set of challenges and procedures; a need for streamlined healthcare experiences is evident.

 

This situation underscores the importance of Lupus Europe possibly looking into how cross-border healthcare in Europe could be simplified and what changes might need to be made to ease the burden on patients navigating these complexities. Addressing this issue could significantly improve the quality of life for those who need to access healthcare services in different European countries.

 

Are you aware of the Lupus Europe Member Capacity Building Programme?

 

No, but now aware!

 

Could you tell us a bit about a dream you have as a group?

 

Yes! Our dream is rooted in the hope that advanced therapies, like CAR-T cell therapy, could become accessible to all eligible patients. Specifically, we dream that CAR-T cell therapy, which is currently expensive and still undergoing clinical trials but has shown promising results, will be available for every lupus patient who can benefit from it.

 

 

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

🧠 Brain fog is real.

For many people living with lupus, it affects everyday life, yet it has often remained difficult to measure.

✅ The new Lupus Brain Fog Severity Scale (LBFSS) is the first questionnaire designed specifically to assess brain fog in lupus.

🦋 Lupus Europe is proud to have contributed to its development through meaningful involvement of people living with lupus. It's another example of how patient perspectives help shape better research and better tools.

🎥 Watch Prof Laurent Arnaud and our Chair, Jeanette Andersen, explain why the LBFSS is such an important step forward in lupus care.

lupus.bmj.com/content/lupusscimed/13/2/e002148.full.pdf
... See MoreSee Less

🦋 Understanding lupus is crucial for effective management and self-management.

💁‍♀️ Many of us know what lupus is, and we’ve been learning from trusted resources like #Lupus100 and #LupusGPT.

🤔 But… how much do we really know about SLE?
Do we know as much as we think we do?

𝐓𝐫𝐲 #𝐒𝐋𝐀𝐊𝐄 𝐚𝐧𝐝 𝐟𝐢𝐧𝐝 𝐨𝐮𝐭❗

🎯 SLAKE (Systemic Lupus Assessment score for Essential Knowledge) is a quick and easy online tool designed for people living with lupus to test their knowledge and learn more about the disease.

📝 44 questions, randomly selected from a pool of 394
⏱️ Around 15 minutes to complete
🌍 Available in 20 languages
📊 A score for each lupus domain and an overall knowledge score

💡 Whether you're newly diagnosed or have been living with lupus for years, SLAKE helps you identify what you already know and where there is room to grow. It is not about passing or failing. It is a chance to learn more and feel more confident when taking part in decisions about your health.

📣 The SLAKE study is still open! By taking part, you are helping researchers understand which aspects of lupus are well understood and where important knowledge gaps remain.

These insights could help guide the potential development of better information resources and tools, tailored to the real needs of people living with lupus in different countries and regions.

SLAKE has been made possible thanks to the leadership of Prof Laurent Arnaud and Dr Antonin Satrin, and the collaboration of an international team of lupus experts and patient representatives.

🥰 Lupus Europe has proudly contributed to this project since the very beginning, and we encourage people living with lupus worldwide to take part while the study remains open.

🔗 Complete SLAKE today and let us know what you think!

lupusresearch.limequery.org/775349
... See MoreSee Less

☀️ As we close our #LupusUVprotection campaign, here is one important reminder:

👉 UV protection in lupus is not only about sunny beach days.

😶‍🌫️ UV exposure can happen on cloudy days, near some windows, while travelling by car, or through certain artificial light sources. And in some people with lupus, its effects may not appear immediately.

‼️ That is why clear, reliable information matters.

Whether you have questions about UV light, photosensitivity, skin symptoms, flares, fatigue, daily life with lupus, or many other lupus-related topics, Lupus Europe provides free, reliable and multilingual tools to support you:

🔹 #𝗟𝘂𝗽𝘂𝘀𝟭𝟬𝟬
Patient-friendly answers to 100 key questions about lupus, including sun exposure and UV protection
lupus100.org/en/questions/can-i-sunbathe-with-lupus

Created with lupus experts & patients. Available in 19 languages.

🔹 #𝗟𝘂𝗽𝘂𝘀𝗚𝗣𝗧
A free artificial intelligence tool to help people find reliable, valid lupus information in almost any language.:
lupusgpt.org/

🔹 #𝗘𝗮𝘀𝘆𝗟𝘂𝗽𝘂𝘀
Like LupusGPT, but designed to make the answers even easier to understand:
easy.lupusgpt.org/

🦋 Because lupus does not only affect clinic appointments. It affects everyday life.

✅ Stay informed. Ask questions. Use reliable resources.
... See MoreSee Less

Image attachment
Image attachment
Image attachment

✅ Yesterday Lupus Europe took part in the DORIS+ meeting in London, alongside clinicians, researchers and patient representatives working on a definition of deep remission in #SLE.

🌟 Lupus Europe was wonderfully represented by Jeanette Andersen, Chair of the Lupus Europe Board, Francesca Marchiori, Lupus Europe Board and PAN Member, Blanca Rubio, PAN Member and Zoe Karakikla-Mitsakou, Lupus Europe General Secretary.

🦋 This continues Lupus Europe involvement in the work on remission in lupus, building on the original DORIS initiative, where Lupus Europe also contributed.

🤔 But what is DORIS?

DORIS stands for Definitions Of Remission In SLE. It helped establish a clinical definition of remission in systemic lupus erythematosus.

🐠 DORIS+ builds on that foundation and explores the concept of deep remission.

💁‍♀️ Since the original DORIS definition was published, emerging evidence has suggested that a deeper state of remission may be within reach for at least some people with lupus. DORIS+ aims to better define what that could mean.

This matters because remission is an important concept for research, clinical care and people living with lupus.

🦋 Lupus Europe is proud to be part of this important taskforce alongside many lupologists and researchers including Prof. Laurent Arnaud, Prof. Ronald van Vollenhoven, Prof. Zahi Touma, Prof. David Isenberg, Prof. Mariele Gatto, Prof. Ioannis Parodis, Prof. Eloisa Bonfá, Prof. Frédéric A. Houssiau, Prof. Andrea Doria, Prof. Ricard Cervera and Prof. Maarten Limper.

😃 We will keep you updated!
... See MoreSee Less

Image attachment
Image attachment
Image attachment
Image attachment
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send